E
Mangoceuticals, Inc. MGRX
$2.04 $0.000.00% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue -39.51% -15.80% 52.24% 245.65% 670.89%
Total Other Revenue -- -- -- -- --
Total Revenue -39.51% -15.80% 52.24% 245.65% 670.89%
Cost of Revenue -33.04% -21.37% 54.52% 256.44% 578.99%
Gross Profit -43.51% -11.94% 50.61% 238.07% 740.10%
SG&A Expenses 1.48% -11.74% 16.43% 31.28% 91.45%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 9.97% 2.41% 27.20% 46.13% 118.35%
Operating Income -15.05% -4.10% -25.28% -37.67% -103.36%
Income Before Tax -23.95% 5.48% -27.45% -40.12% -97.83%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -23.95% 5.48% -27.45% -40.12% -97.83%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -23.94% 5.49% -27.43% -40.11% -97.83%
EBIT -15.05% -4.10% -25.28% -37.67% -103.36%
EBITDA -1.48% 4.84% -25.41% -65.42% -201.92%
EPS Basic 38.64% 46.44% 27.43% 16.50% -18.25%
Normalized Basic EPS 43.18% 50.05% 27.43% 16.50% -18.25%
EPS Diluted 38.64% 46.44% 27.43% 16.50% -18.25%
Normalized Diluted EPS 43.18% 50.05% 27.43% 16.50% -18.25%
Average Basic Shares Outstanding 119.36% 90.36% 76.59% 68.85% 71.36%
Average Diluted Shares Outstanding 119.36% 90.36% 76.59% 68.85% 71.36%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --